Optimizing Outcomes in Newly Diagnosed Multiple Myeloma: Integrating Anti-CD38 Monoclonal Antibody Therapy Into Clinical Practice
Did you miss the latest updates on multiple myeloma presented at ASH 2021? Join Dr Faith Davies and Dr Nina Shah as they review late-breaking data on approved and emerging therapies for newly diagnosed multiple myeloma!
https://learning.freecme.com/a/38663PA6uG2J